PGC-1α regulation of mitochondrial degeneration in experimental diabetic neuropathy

Akude, 2009, 4-Hydroxy-2-nonenal induces mitochondrial dysfunction and aberrant axonal outgrowth in adult sensory neurons that mimics features of diabetic neuropathy, Neurotox. Res., 17, 28, 10.1007/s12640-009-9074-5 Andreasson, 2002, Real-time DNA quantification of nuclear and mitochondrial DNA in forensic analysis, Biotechniques, 33, 402, 10.2144/02332rr07 Andrulionyte, 2007, Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial, Diabetes, 56, 1181, 10.2337/db06-1110 Anjaneyulu, 2008, Transforming growth factor-beta induces cellular injury in experimental diabetic neuropathy, Exp. Neurol., 211, 469, 10.1016/j.expneurol.2008.02.011 Aquilano, 2013, Extranuclear localization of SIRT1 and PGC-1alpha: an insight into possible roles in diseases associated with mitochondrial dysfunction, Curr. Mol. Med., 13, 140, 10.2174/156652413804486241 Baar, 2002, Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1, FASEB J., 16, 1879, 10.1096/fj.02-0367com Berent-Spillson, 2007, Metabotropic glutamate receptor 3 protects neurons from glucose-induced oxidative injury by increasing intracellular glutathione concentration, J. Neurochem., 101, 342, 10.1111/j.1471-4159.2006.04373.x Bogacka, 2005, Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo, Diabetes, 54, 1392, 10.2337/diabetes.54.5.1392 Brand, 2011, Assessing mitochondrial dysfunction in cells, Biochem. J., 435, 297, 10.1042/BJ20110162 Brownlee, 2000, Negative consequences of glycation, Metabolism, 49, 9, 10.1016/S0026-0495(00)80078-5 Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a Callaghan, 2012, Diabetic neuropathy: clinical manifestations and current treatments, Lancet Neurol., 11, 521, 10.1016/S1474-4422(12)70065-0 Canto, 2011, Calorie restriction: is AMPK a key sensor and effector?, Physiol. (Bethesda), 26, 214, 10.1152/physiol.00010.2011 Choi, 2002, Identification of oxidized plasma proteins in Alzheimer's disease, Biochem. Biophys. Res. Commun., 293, 1566, 10.1016/S0006-291X(02)00420-5 Choi, 2013, A novel PGC-1alpha isoform in brain localizes to mitochondria and associates with PINK1 and VDAC, Biochem. Biophys. Res. Commun., 435, 671, 10.1016/j.bbrc.2013.05.041 Chowdhury, 2013, The role of aberrant mitochondrial bioenergetics in diabetic neuropathy, Neurobiol. Dis., 56, 10.1016/j.nbd.2012.03.016 Christianson, 2003, Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice, Exp. Neurol., 179, 188, 10.1016/S0014-4886(02)00017-1 Coppey, 2006, ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats, Diabetes, 55, 341, 10.2337/diabetes.55.02.06.db05-0885 Cowell, 2007, Localization of the transcriptional coactivator PGC-1alpha to GABAergic neurons during maturation of the rat brain, J. Comp. Neurol., 502, 1, 10.1002/cne.21211 Cowell, 2009, Identification of novel targets for PGC-1alpha and histone deacetylase inhibitors in neuroblastoma cells, Biochem. Biophys. Res. Commun., 379, 578, 10.1016/j.bbrc.2008.12.109 Esterbauer, 1999, Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression, Genomics, 62, 98, 10.1006/geno.1999.5977 Finkel, 2006, Cell biology: a clean energy programme, Nature, 444, 151, 10.1038/444151a He, 2002, Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR, Nucleic Acids Res., 30, e68, 10.1093/nar/gnf067 Heilbronn, 2007, Impaired fat oxidation after a single high-fat meal in insulin-sensitive nondiabetic individuals with a family history of type 2 diabetes, Diabetes, 56, 2046, 10.2337/db06-1687 Ho, 2006, Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage, Diabetes, 55, 1946, 10.2337/db05-1497 Huang, 2003, Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia, Diabetes, 52, 2129, 10.2337/diabetes.52.8.2129 Johri, 2012, Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease, Hum. Mol. Genet., 21, 1124, 10.1093/hmg/ddr541 Kelly, 2004, Transcriptional regulatory circuits controlling mitochondrial biogenesis and function, Genes Dev., 18, 357, 10.1101/gad.1177604 Kishi, 2002, Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy, Diabetes, 51, 819, 10.2337/diabetes.51.3.819 Kleiner, 2012, Development of insulin resistance in mice lacking PGC-1alpha in adipose tissues, Proc. Natl. Acad. Sci. U.S.A., 109, 9635, 10.1073/pnas.1207287109 Lauria, 2005, EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy, Eur. J. Neurol., 12, 747, 10.1111/j.1468-1331.2005.01260.x Lauria, 2005, Intraepidermal nerve fiber density in rat foot pad: neuropathologic–neurophysiologic correlation, J. Peripher. Nerv. Syst., 10, 202, 10.1111/j.1085-9489.2005.0010210.x Lehman, 2000, Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis, J. Clin. Invest., 106, 847, 10.1172/JCI10268 Leone, 2005, PGC-1α deficient mice exhibit multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control, and hepatic steatosis, PLoS Biol., e101, 10.1371/journal.pbio.0030101 Lin, 2002, Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres, Nature, 418, 797, 10.1038/nature00904 Lin, 2004, Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice, Cell, 119, 125, 10.1016/j.cell.2004.09.013 Mallon, 2005, In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA, J. Infect. Dis., 191, 1686, 10.1086/429697 Martin-Gallan, 2003, Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications, Free Radic. Biol. Med., 34, 1563, 10.1016/S0891-5849(03)00185-0 Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat. Genet., 34, 267, 10.1038/ng1180 Nystrom, 2005, Role of oxidative carbonylation in protein quality control and senescence, EMBO J., 24, 1311, 10.1038/sj.emboj.7600599 Obrosova, 2002, How does glucose generate oxidative stress in peripheral nerve?, Int. Rev. Neurobiol., 50, 3, 10.1016/S0074-7742(02)50071-4 Obrosova, 2005, Aldose reductase inhibition counteracts oxidative–nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications, Diabetes, 54, 234, 10.2337/diabetes.54.1.234 Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1, Proc. Natl. Acad. Sci. U.S.A., 100, 8466, 10.1073/pnas.1032913100 Puigserver, 2003, Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator, Endocr. Rev., 24, 78, 10.1210/er.2002-0012 Puigserver, 1998, A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell, 92, 829, 10.1016/S0092-8674(00)81410-5 Roy Chowdhury, 2012, Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes, Brain, 135, 1751, 10.1093/brain/aws097 Russell, 1999, Neurons undergo apoptosis in animal and cell culture models of diabetes, Neurobiol. Dis., 6, 347, 10.1006/nbdi.1999.0254 Russell, 2002, High glucose-induced oxidative stress and mitochondrial dysfunction in neurons, FASEB, 16, 1738, 10.1096/fj.01-1027com Russell, 2008, Oxidative injury and neuropathy in diabetes and impaired glucose tolerance, Neurobiol. Dis., 30, 420, 10.1016/j.nbd.2008.02.013 Sasaki, 1997, Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats, Acta Neuropathol., 93, 118, 10.1007/s004010050592 Schuh, 2005, Methoxychlor inhibits brain mitochondrial respiration and increases hydrogen peroxide production and CREB phosphorylation, Toxicol. Sci., 88, 495, 10.1093/toxsci/kfi334 Smith, 2006, Lifestyle intervention for prediabetic neuropathy, Diabetes Care, 29, 1294, 10.2337/dc06-0224 Song, 2003, Transgenic mice overexpressing aldose reductase in Schwann cells show more severe nerve conduction velocity deficit and oxidative stress under hyperglycemic stress, Mol. Cell. Neurosci., 23, 638, 10.1016/S1044-7431(03)00096-4 Soyal, 2012, A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset, Hum. Mol. Genet., 21, 3461, 10.1093/hmg/dds177 St Pierre, 2006, Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators, Cell, 20, 397, 10.1016/j.cell.2006.09.024 Toth, 2007, Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy, Diabetes, 57, 1002, 10.2337/db07-0339 Turk, 2009, Glycotoxines, carbonyl stress and relevance to diabetes and its complications, Physiol. Res., 59, 147 Vincent, 2004, Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death, Diabetes, 53, 726, 10.2337/diabetes.53.3.726 Vincent, 2006, RAGE activation injures primary sensory neurons via oxidative stress, Endocrinology, 148, 548, 10.1210/en.2006-0073 Vincent, 2007, Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress, Endocrinology, 148, 548, 10.1210/en.2006-0073 Vincent, 2007, SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy, Exp. Neurol., 208, 216, 10.1016/j.expneurol.2007.07.017 Vincent, 2009, Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1, Diabetes, 58, 2376, 10.2337/db09-0047 Vinik, 2005, The protein kinase C-beta inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications, Expert Opin. Investig. Drugs, 14, 1547, 10.1517/13543784.14.12.1547 Wiggin, 2009, Elevated triglycerides correlate with progression of diabetic neuropathy, Diabetes, 58, 1634, 10.2337/db08-1771 Wu, 1999, Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1, Cell, 98, 115, 10.1016/S0092-8674(00)80611-X Yagihashi, 2001, Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor, Brain, 124, 2448, 10.1093/brain/124.12.2448 Yu, 2012, Salvianolic acid A protects the peripheral nerve function in diabetic rats through regulation of the AMPK-PGC1alpha-Sirt3 axis, Molecules, 17, 11216, 10.3390/molecules170911216